How to Navigate Ecosystem Connect NEWDistinguished Investigators Global Conferences RLT Education RLT Components Sponsors Trial Stats
A Phase I Study to Evaluate the Safety and Dosimetry of 68Ga-OncoACP3 in Patients with Prostate Cancer
Description:
The aim of this study is to assess the safety and dosimetry of [68Ga]Ga-OncoACP3 in patients with prostate cancer.
Sponsor:
Philogen S.p.A.
Contacts:
Marco Taras (Biologist)regulatory@philogen.com
+39 057717816
Jacqueline Mock, PhDregulatory@philogen.com
+41 43 544 88 02
Government Study Link:
NCT06840535 - Click here to see study onClinicalTrials.gov
68Ga-OncoACP3
Isotope(s):
Target(s):
- Acid Phosphatase 3 (ACP3)
